Skip to content

    ASHP® Injectable Drug Information™

    Hero Background Image

    Title Details

    2025 Ed.

    ASHP®

    ISBN-13: 978-1-58528-743-7

    eISBN-13: 978-1-58528-744-4

    Drug Information, Pharmacy/Pharmacology, Nursing, Point of Care

    Additional Details

    Description
    Audience
    Doody's Reviews

    Backed by quality, peer-reviewed published literature, ASHP® Injectable Drug Information™ has been one of pharmacy’s most trusted resources for more than four decades.

    Authored under the editorial authority of AHFS Drug Information® and published by ASHP, it is the global gold standard for IV compatibility and stability information.

    The 2025 Edition of the industry’s go-to guide is newly updated with the latest information, ASHP’s Standardize 4 Safety (S4S) concentration standards including new Adult and Pediatric PCA and Epidural standard concentrations, the full list of the AHFS® Pharmacologic-Therapeutic Classification© system, 25 new monographs, and more than 270 new references for a total of over 25,000 total compatibility pairs.

    ASHP® Injectable Drug Information™ 2025 features more than 420 monographs, including:

    • • Sulbactam Sodium and Durlobactam Sodium
    • • Rezafungin Acetate
    • • Ublituximab
    • • Mosnetuzumab
    • • Teplizumab
    • • Terlipresssin Acetate
    • • Tecovirimat

    Table of Contents

    Similar Resources

    Cards Background

    The Power of A Digital Library

    TDS Health titles provide the latest healthcare information in a customizable and convenient format. STAT!Ref goes where you go, accessible by desktop, laptop, wireless or web-enabled mobile devices. Harness the power of learning in you hands.

    1
    TEAM DEDICATED TO YOUR LEARNING SUCCESS
    50
    Healthcare Disciplines
    500 +
    DIGITAL MEDICAL TITLES AVAILABLE
    CTA Background Image